Leveraging iPSC technology to assess neuro-immune interactions in neurological and psychiatric disorders is a research paper published in Frontiers in Psychiatry (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: AG065611
National Institutes of Health
Grant: AG079256
National Institutes of Health
Grant: MH123711
National Institutes of Health
Grant: MH132012
Department of Defense
Grant: W81XWH1910353
NIA NIH HHS
Grant: R01 AG065611
NIMH NIH HHS
Grant: R21 MH123711
NIMH NIH HHS
Grant: R21 MH132012
NIA NIH HHS
Grant: RF1 AG079256
National Institutes of Health
Grant: 1R21MH123711-01
Towards a Better Understanding of Fragile X Syndrome Using Human Brain Organoids
National Institutes of Health
Grant: 1R21MH132012-01
Using Human iPSC Models to Determine the Mechanism of Inflammation-Induced Disruption of Dopamine Neurotransmission
National Institutes of Health
Grant: 1RF1AG079256-01
Understanding the functional impacts of Aβ variants in Alzheimer's disease with human brain organoids
National Institutes of Health
Grant: 5R01AG065611-04
Towards a better understanding of genetic architecture of Alzheimer's disease with human iPSC models
PhRMA Foundation
FWCI
0.67
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals